CORAL GABLES, Fla., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that Dr. Richard B. Silverman, a renowned expert in the field of rational drug design, on the biochemistry of GABA aminotransferase (GABA-AT), and the lead inventor on the team that invented CPP-115, gave a presentation entitled "CPP-115: A GABA Aminotransferase Inactivator and New Treatment for Drug Addiction and Epilepsy" at the American Chemical Society Annual Fall Meeting in Denver, Colorado on Monday, August 29, 2011.
